OSA is categorized by severity, and mild sleep apnea can often be minimized through lifestyle changes. Quitting smoking and ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

When it comes to health foods, cheese is a champ. For starters, dietary gurus have decreed that unlike the mostly saturated ...

对于某些非肥胖而口咽部阻塞明显的重度OSA患者，可以考虑在应用CPAP治疗1～2个月、夜间呼吸暂停及低氧已基本纠正情况下施行UPPP手术治疗。术前和术中应严密监测患者的情况，术后必须定期随访，如手术失败，应使用CPAP治疗 [4] 。

Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

PROVIGIL and NUVIGIL become the latest branded medicines to be sold in the United States within the Apotex Group's diversified global portfolio of products.

After one month, the study participants had their sleep assessed according to the Pittsburgh Sleep Quality Index. Those who ...

Performance Home Medical plans to use an additional $55 million investment from Grant Avenue Capital to shift its business ...

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...